• Government of Quebec offers improved access to diabetes treatments firstwordpharma
    November 29, 2018
    Boehringer Ingelheim (Canada) Ltd. and Eli Lilly Canada Inc. announced today the Government of Quebec will continue to provide public funding of JARDIANCE® (empagliflozin), SYNJARDY® (a single-pill combination of empagliflozin and metformin), and TRAJENTA
  • Government of Quebec offers improved access to diabetes treatments firstwordpharma
    November 29, 2018
    Boehringer Ingelheim (Canada) Ltd. and Eli Lilly Canada Inc. announced today the Government of Quebec will continue to provide public funding of JARDIANCE® (empagliflozin), SYNJARDY® (a single-pill combination of empagliflozin and metformin), and TRAJENTA
PharmaSources Customer Service